EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 47 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,976,368 | -24.9% | 344,916 | +1.6% | 0.00% | -100.0% |
| Q2 2023 | $2,630,792 | +28.9% | 339,457 | +10.9% | 0.00% | – |
| Q1 2023 | $2,041,580 | -27.9% | 306,084 | -3.4% | 0.00% | -100.0% |
| Q4 2022 | $2,832,479 | +20.5% | 316,832 | +32.6% | 0.00% | 0.0% |
| Q3 2022 | $2,351,000 | +35.9% | 238,900 | +10.0% | 0.00% | – |
| Q2 2022 | $1,730,000 | -39.3% | 217,267 | -26.1% | 0.00% | -100.0% |
| Q1 2022 | $2,852,000 | -38.2% | 293,952 | -2.7% | 0.00% | 0.0% |
| Q4 2021 | $4,617,000 | +140.7% | 302,190 | +161.5% | 0.00% | – |
| Q3 2021 | $1,918,000 | -29.0% | 115,573 | -8.8% | 0.00% | – |
| Q2 2021 | $2,703,000 | – | 126,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |